Belgium· BE-AMP-SAM138537-00
Miostat 0.01 %
A carbachol product containing carbachol, registered in Belgium by Alcon. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Carbachol is registered in 10 of 19 countries.
Countries holding a registration under ATC S01EB02 (carbachol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Carbachol · ATC S01EB02
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Carbachol
- Manufacturer
- Alcon
- Country
- Belgium (BE)
- ATC code
- S01EB02
- ATC class
- Carbachol
- Defined daily dose
- 0.4 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0668624
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carbachol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarbachol 250micrograms/1ml solution for injection ampoulesSpecial Order
- FinlandDorylMerck KGaA
- CzechiaMIOSTAT
- FranceMIOSTAT 100 microgrammes/ml, solution injectable pour voie intra-oculaireLABORATOIRES ALCON
- NetherlandsMIOSTAT, oplossing voor injectie voor intra-oculair gebruik 0,1 mg/mlAlcon Nederland B.V.
- NorwayMiostat intraokulærAlcon
- PolandMiostatAlcon Polska Sp. z o.o.
- SwedenMiostat 100 mikrogram/ml Injektionsvätska, lösning, för intraokulär användningAlcon Nordic A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- France · Miostat
- Netherlands · Miostat
- Poland · Miostat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3b60e804-4901-40c5-8412-087b7f1b2d2d GET /v1/drugs/3b60e804-4901-40c5-8412-087b7f1b2d2d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Intraocular instillation solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Miostat 0.01 %",
"name_fr": "Miostat 0.01 %",
"name_nl": "Miostat 0.01 %",
"amp_code": "SAM138537-00",
"strengths": [
"0.1000",
"0.7500",
"3.9000",
"6.4000"
],
"pack_count": 2,
"substances": [
"Carbachol",
"Potassium Chloride",
"Sodium Acetate Trihydrate",
"Sodium Chloride",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Carbachol",
"authorisation_numbers": [
"BE138537"
]
}See everything about carbachol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.